These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 12511748)

  • 1. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
    Castellanos M; Leira R; Serena J; Pumar JM; Lizasoain I; Castillo J; Dávalos A
    Stroke; 2003 Jan; 34(1):40-6. PubMed ID: 12511748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
    Montaner J; Alvarez-Sabín J; Molina CA; Anglés A; Abilleira S; Arenillas J; Monasterio J
    Stroke; 2001 Dec; 32(12):2762-7. PubMed ID: 11739970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
    Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
    Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of FSTL1 and MMP-9 levels in patients with acute cerebral infarction and its relationship with hemorrhagic transformation.
    Ling C; Cao S; Kong X
    J Clin Neurosci; 2022 May; 99():164-168. PubMed ID: 35286969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
    Castellanos M; Sobrino T; Millán M; García M; Arenillas J; Nombela F; Brea D; Perez de la Ossa N; Serena J; Vivancos J; Castillo J; Dávalos A
    Stroke; 2007 Jun; 38(6):1855-9. PubMed ID: 17478737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
    Montaner J; Molina CA; Monasterio J; Abilleira S; Arenillas JF; Ribó M; Quintana M; Alvarez-Sabín J
    Circulation; 2003 Feb; 107(4):598-603. PubMed ID: 12566373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion.
    Molina CA; Alvarez-Sabín J; Montaner J; Abilleira S; Arenillas JF; Coscojuela P; Romero F; Codina A
    Stroke; 2002 Jun; 33(6):1551-6. PubMed ID: 12052990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).
    Leira R; Sobrino T; Blanco M; Campos F; Rodríguez-Yáñez M; Castellanos M; Moldes O; Millán M; Dávalos A; Castillo J
    Clin Sci (Lond); 2012 Feb; 122(3):113-9. PubMed ID: 21861843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of plasma matrix metalloproteinase-9 concentrations for spontaneous haemorrhagic transformation in patients with acute ischaemic stroke: A cohort study in Chinese patients.
    Yuan R; Tan S; Wang D; Wu S; Cao X; Zhang S; Wu B; Liu M
    J Clin Neurosci; 2018 Dec; 58():108-112. PubMed ID: 30287248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of risk factors of hemorrhagic transformation after acute ischemic stroke: cerebral microbleeds do not correlate with hemorrhagic transformation.
    Wang BG; Yang N; Lin M; Lu B
    Cell Biochem Biophys; 2014 Sep; 70(1):135-42. PubMed ID: 24691925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
    Jha R; Battey TW; Pham L; Lorenzano S; Furie KL; Sheth KN; Kimberly WT
    Stroke; 2014 Apr; 45(4):1040-5. PubMed ID: 24619394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.
    Foerch C; Wunderlich MT; Dvorak F; Humpich M; Kahles T; Goertler M; Alvarez-Sabín J; Wallesch CW; Molina CA; Steinmetz H; Sitzer M; Montaner J
    Stroke; 2007 Sep; 38(9):2491-5. PubMed ID: 17673718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.
    Mallolas J; Rodríguez R; Gubern C; Camós S; Serena J; Castellanos M
    Neuromolecular Med; 2014 Dec; 16(4):856-61. PubMed ID: 25344020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased blood-brain barrier permeability on perfusion computed tomography predicts hemorrhagic transformation in acute ischemic stroke.
    Ozkul-Wermester O; Guegan-Massardier E; Triquenot A; Borden A; Perot G; Gérardin E
    Eur Neurol; 2014; 72(1-2):45-53. PubMed ID: 24853726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease.
    Liu J; Wang D; Li J; Lin J; Xiong Y; Liu B; Wei C; Wu B; Ma Z; Zhang S; Liu M
    Curr Neurovasc Res; 2017; 14(2):104-109. PubMed ID: 28294063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
    Montaner J; Alvarez-Sabín J; Molina C; Anglés A; Abilleira S; Arenillas J; González MA; Monasterio J
    Stroke; 2001 Aug; 32(8):1759-66. PubMed ID: 11486102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
    Cojocarui IM; Cojocaru M; Sapira V; Socoliuc G; Hertea C; Paveliu S
    Rom J Intern Med; 2012; 50(2):155-8. PubMed ID: 23326959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
    Kelly PJ; Morrow JD; Ning M; Koroshetz W; Lo EH; Terry E; Milne GL; Hubbard J; Lee H; Stevenson E; Lederer M; Furie KL
    Stroke; 2008 Jan; 39(1):100-4. PubMed ID: 18063832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.
    Rosell A; Ortega-Aznar A; Alvarez-Sabín J; Fernández-Cadenas I; Ribó M; Molina CA; Lo EH; Montaner J
    Stroke; 2006 Jun; 37(6):1399-406. PubMed ID: 16690896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.